Trials / Sponsors / TerSera Therapeutics LLC
TerSera Therapeutics LLC
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+ Advanced Breast Cancer | Phase 1 | 2026-04-29 |
| Completed | Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine Oncology Patients Receiving Chemotherapy | Phase 2 | 2020-03-25 |
| Terminated | A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Canc Biliary Tract Cancer (BTC) | Phase 2 | 2019-03-13 |
| Completed | Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO Carcinoid Syndrome | — | 2017-06-22 |
| Approved For Marketing | Margetuximab Expanded Access Program HER2-positive Breast Cancer, HER2-positive Carcinoma | — | — |